Literature DB >> 16328113

Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence.

María-Teresa Castillo-Vico1, Miguel A Checa-Vizcaíno, Antonio Payà-Panadés, Carolina Rueda-García, Ramón Carreras-Collado.   

Abstract

Periurethral injection of bulk-enhancing agents provides a simpler and cost-effective therapeutic approach for stress incontinence in women. We report a case of periurethral granuloma secondary to dextranomer/hyaluronic acid (Dx/HA) copolymer injection. A 73-year-old woman with history of radiotherapy for cervical carcinoma at the age of 55 presented with stress urinary incontinence. She underwent periurethral injection of Dx/HA copolymer, and incontinence was resolved. At 4 months postoperatively, a 3-4 cm noninflammatory painless mass in the external genitalia was noted. Cystic images compatible with urethral diverticula were seen in the magnetic resonance imaging scan, but voiding cystourethrography was unrevealing. Transvaginal tumor puncture yielded abundant creamy material, the culture of which was negative. Microscopic examination revealed refractile foreign material surrounded by foreign body giant cells. Surgical debridement of the granuloma using a cold scalpel was performed. Stress urinary incontinence recurred but resolved spontaneously within 1 month. One year later, the patient continues to be asymptomatic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328113     DOI: 10.1007/s00192-005-0049-7

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  12 in total

1.  Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis.

Authors:  A Stenberg; E Larsson; A Lindholm; B Ronneus; A Stenberg; G Läckgren
Journal:  Scand J Urol Nephrol       Date:  1999-12

2.  [Validity of the King's Health questionnaire in the assessment of quality of life of patients with urinary incontinence. The King's Group].

Authors:  X Badia Llach; D Castro Díaz; J Conejero Sugrañes
Journal:  Med Clin (Barc)       Date:  2000-05-06       Impact factor: 1.725

3.  [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results].

Authors:  J Alonso; L Prieto; J M Antó
Journal:  Med Clin (Barc)       Date:  1995-05-27       Impact factor: 1.725

Review 4.  Injection therapy for stress incontinence in women.

Authors:  T H Su; C Y Hsu; J C Chen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1999

5.  Complications of periurethral collagen injection for stress urinary incontinence.

Authors:  L Stothers; S L Goldenberg; E F Leone
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

6.  Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder.

Authors:  A M Stenberg; A Sundin; B S Larsson; G Läckgren; A Stenberg
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

7.  Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections.

Authors:  Jane A Schulz; Charles W Nager; Stuart L Stanton; Kaven Baessler
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

8.  Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.

Authors:  A Stenberg; E Larsson; G Läckgren
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

9.  Periurethral fat injection in the treatment of recurrent genuine stress incontinence.

Authors:  T H Su; K G Wang; C Y Hsu; H J Wei; H J Yen; F C Shien
Journal:  J Urol       Date:  1998-02       Impact factor: 7.450

10.  Urinary retention and intravesical hemorrhage following urethral collagen injections in women using warfarin.

Authors:  J P Theofrastous; K Simpkins
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2002
View more
  3 in total

Review 1.  Benign masses of the female periurethral tissues and anterior vaginal wall.

Authors:  Sophie G Fletcher; Gary E Lemack
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

2.  An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence.

Authors:  Gunnar Lose; Helle Christina Sørensen; Susanne M Axelsen; Christian Falconer; Kurt Lobodasch; Tosson Safwat
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

Review 3.  Urethral bulking agents: techniques and outcomes.

Authors:  Ahmed F Kotb; Lysanne Campeau; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.